Singapore’s National University Cancer Institute welcomes new director | Healthcare Asia Magazine
, Singapore
469 views
NCIS welcomes new director, Chee Cheng Ean. Image source: NCIS

Singapore’s National University Cancer Institute welcomes new director

The outgoing director is exiting after nine years of service

The National University Cancer Institute, Singapore (NCIS) has appointed Chee Cheng Ean as its new director starting 1 September.

Chee, an associate professor of Medicine at National University of Singapore (NUS), took over the senior role as Chng Wee Joo bowed out after nine years of service.

Chng’s leadership that started in 2014, sparked clinical trials on stem cell transplants, cancer care delivery, and cellular therapy in the NCIS which now handles more than 200 studies a year. It was also under his term that the NCIS attained world-class outcomes for stem cell transplants for blood cancers, lung cancer, and urologic cancer.

In welcoming their new leader, Chng said Chee has played crucial role in the clinical transformation of NCIS over the past years and she is well-positioned to lead the institution’s new growth path

“Together, we will leverage cutting-edge research, the latest technological advancements, and the power of multidisciplinary collaboration to drive us towards our vision for 2030,” said Chee, who has been the clinical deputy director at NCIS since April 2021.

Chee specialises in colorectal, liver and pancreatic cancers at NCIS, with active involvement in clinical medicine and oncology, being a grant-winning, widely-published clinical investigator.

She was among the team behind the award-winning NCIS Survivorship Programme, which focused on follow-up care for cancer patients in the community. During the pandemic, she also led successful initiatives that improved patient care and operations at NCIS.

For the outgoing official, Chng will continue to hold directorships at a number of medical institutions in the city-state, including the National University Health System Research Office, NUS Cancer Science Institute of Singapore and the Singapore Translational Cancer Consortium.

“Moving forward, I will focus on strengthening research in NUHS by harnessing the power of all the schools and disciplines in the National University of Singapore and the clinical expertise in NUHS, to work together to solve problems in the health of the population we serve,” said Chng.

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

Kejeniusan dalam ‘SuperApps’ untuk perawatan kesehatan adalah akses dan jangkauan

Rumah sakit yang merangkul digitalisasi tetap unggul dalam layanan kesehatan.

Rumah Sakit Kanker Dharmais memimpin inovasi pelayanan kanker di Indonesia

Direktur Utama RS Kanker Dharmais Soeko Werdi Nindito Daroekoesoemo mengungkapkan teknologi canggih dan tujuh program unggulan untuk perawatan kanker.

Healthway Cancer Care Hospital memajukan perawatan holistik dengan harga yang wajar

Rumah sakit mengharapkan program kualitas dan kelangsungan hidup yang melayani keseluruhan perjalanan pasien.

MakatiMed menuju perawatan bedah presisi dengan sistem robotik Da Vinci Xi

Teknologi ini memungkinkan teknik invasif minimal dalam bidang urologi, hepatobilier, kardiovaskular, toraks, kebidanan dan ginekologi, serta bedah umum.

Indonesia memperluas dukungan solusi kesehatan menggunakan AI

Kolaborasi dengan Google Cloud sejalan dengan cetak biru pemerintah untuk transformasi kesehatan digital.

Indonesia merancang rencana induk untuk pengembangan kesehatan terpadu

Rencana induk sektor kesehatan negara (RIBK) selaras dengan mandat Undang-Undang Kesehatan Nomor 17 Tahun 2023.

The Medical City membuka jalan bagi integrasi AI dalam layanan kesehatan lokal dan penelitian dengan Lunit

AI telah diintegrasikan ke dalam layanan mamografi dan rontgen dada di jaringan rumah sakit ini.

Mayapada Healthcare Group meraih prestasi besar di Healthcare Asia Awards 2024

Pendekatan holistik yang dilakukan oleh rumah sakit tersebut mendorongnya maju dan menjadi standar industri.

Rumah Sakit Kanker Dharmais meraih dua kemenangan di Healthcare Asia Awards 2024

Sumber daya manusia yang kompeten, layanan, fasilitas, dan infrastruktur unggul membantu rumah sakit memberikan perawatan pasien yang sangat baik.